CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity
Science Immunology · 19.12.2025 · 10 (114)
DOI: 10.1126/sciimmunol.adz2294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 19.12.2025. Verfasst von Bin-Jin Hwang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University, Durham, NC, USA. Hauptthemen laut MEDLINE: Tumor Necrosis Factor Receptor Superfamily, Member 7, Cancer Vaccines, CD4-Positive T-Lymphocytes, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Institutes of Health, U.S. Department of Defense.
Abstract (Originalsprache)
Tumor antigen vaccination represents an appealing approach for cancer but has failed to materialize as oncologic standard of care. To understand long-term vaccine efficacy, we conducted a retrospective analysis of patients with human epidermal growth receptor 2 + (HER2 + ) breast cancer who received HER2-targeting vaccines and survived for >18 years. PBMC analysis revealed HER2-specific CD27 + memory CD4 and CD8 T cells, suggesting that CD27 signaling supports long-term immune memory. In human CD27 transgenic mice, combining HER2 vaccination with anti-CD27 agonism enhanced HER2-specific responses, particularly long-lived CD4 memory T cells. Murine models demonstrated ~40% tumor regression with combined therapy compared with vaccine alone (~6%). Additional scRNA-seq analysis identified CD4 T cells with a distinct gene expression profile, and depletion/adoptive transfer studies validated that CD4 T cells were essential for this effect. These findings suggest that CD27 agonism enhances vaccine-induced antigen-specific CD4 T cell responses, enabling durable antitumor immunity not entirely dependent on CD8 T cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Duke University, Durham, NC, USA.
- Department of Integrative Immunobiology, Duke University, Durham, NC, USA.
- Department of Pathology, Duke University, Durham, NC, USA.
- Department of Medicine, Duke University, Durham, NC, USA.
- School of Medicine, Duke University, Durham, NC, USA.
- Celldex Therapeutics Inc., Hampton, NJ, USA.
ORCID-Profile: Bin-Jin Hwang, Erika J Crosby, Timothy N Trotter, Jason McBane, Li-Chung Tsao, Gangjun Lei, Junping Wei, Xingru Ma, Amy Hobeika, Michael Morse, Ethan Agritelley, Karrie Comatas, Herbert Kim Lyerly, Zachary C Hartman
Förderung
- National Institutes of Health
- U.S. Department of Defense
Zitieren
APA
Hwang, B. J., Crosby, E. J., Severson, D. T., Trotter, T. N., McBane, J., Tsao, L. C., Wang, T., Liu, C. X., Yang, X. Y., Lei, G., Wei, J., Ma, X., Liu, B., Hobeika, A., Morse, M., Joseph, J., Agritelley, E., Kanu, E., Comatas, K., …, & Hartman, Z. C. (2025). CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity. Science Immunology, 10(114). https://doi.org/10.1126/sciimmunol.adz2294
Vancouver
Hwang BJ, Crosby EJ, Severson DT, Trotter TN, McBane J, Tsao LC, et al. CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity. Science Immunology. 2025;10(114). doi:10.1126/sciimmunol.adz2294
BibTeX
@article{Hwang2025,
author = {Hwang, Bin-Jin and Crosby, Erika J and Severson, David T and Trotter, Timothy N and McBane, Jason and Tsao, Li-Chung and Wang, Tao and Liu, Cong-Xiao and Yang, Xiao-Yi and Lei, Gangjun and Wei, Junping and Ma, Xingru and Liu, Bushanqing and Hobeika, Amy and Morse, Michael and Joseph, Jesuchristopher and Agritelley, Ethan and Kanu, Elishama and Comatas, Karrie and Keler, Tibor and He, Li-Zhen and Lyerly, Herbert Kim and Hartman, Zachary C},
title = {CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunity},
journal = {Science Immunology},
year = {2025},
volume = {10},
number = {114},
doi = {10.1126/sciimmunol.adz2294}
}
EUVIMED